Biomarker discovery in breath and biofluids

Unlocking the Potential of VOCs in Disease Detection: Biomarker discovery in breath and other biological samples

The accurate identification and measurement of biomarkers in biological samples – such as breath and biofluids – has the potential to provide rapid, early detection of a range of physiological and pathological conditions.

Volatile organic compounds (VOCs) released by the human body offer promising potential for non-invasive disease diagnosis. These compounds serve as biomarkers, reflecting physiological conditions and aiding in the detection of abnormalities.

Non-invasive biological samples are of most interest, such as:

Breath
Urine

Why is this important?

Enabling early detection
Reducing healthcare costs
Supporting large-scale screening programs

How can Markes help?

The powerful combination of PAL3 automation with cryogen-free trap focusing on the Centri platform enables:

Highly sensitive identification of trace biomarkers in complex samples.
Versatile, robust and reproducible VOC sampling using different methods on one GC(-MS) – HS, SPME, TD and HiSorb.

Contact LinkedIn